Publicacións nas que colabora con Jesús Rodríguez-Baño (17)

2023

  1. Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection

    Frontiers in Medicine, Vol. 10

2019

  1. Combined use of the Ab105-2ϕ∆CI lytic mutant phage and different antibiotics in clinical isolates of multi-resistant Acinetobacter baumannii

    Microorganisms, Vol. 7, Núm. 11

2018

  1. Relationship between the Quorum network (sensing/quenching) and clinical features of pneumonia and bacteraemia caused by A. Baumannii

    Frontiers in Microbiology, Vol. 9

2017

  1. Overproduction of Outer membrane protein a by Acinetobacter baumannii as a risk factor for nosocomial pneumonia, bacteremia, and mortality rate increase

    Journal of Infectious Diseases, Vol. 215, Núm. 6, pp. 966-974

  2. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme

    PLoS ONE, Vol. 12, Núm. 3

  3. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Acinetobacter baumannii in critically ill patients: Molecular epidemiology, clinical features and predictors of mortality

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 9, pp. 551-558

2015

  1. Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish society of infectious diseases and clinical microbiology

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 5, pp. 337.e1-337.e21

  2. Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 5, pp. 338-341

  3. Reduced susceptibility to biocides in Acinetobacter baumannii: Association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

    Journal of Antimicrobial Chemotherapy, Vol. 70, Núm. 12, pp. 3222-3229

2014

  1. Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 10, pp. 2629-2633

  2. Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal

    Medicine (United States), Vol. 93, Núm. 5, pp. 202-210

  3. Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: Analysis of a multicentre prospective cohort

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 11, pp. 3119-3126

2013

  1. Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 1, pp. 4-9

  2. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 11, pp. 5247-5257

  3. Erratum: Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: Segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010) (Enfermedades Infecciosas y Microbiologia Clinica (2013) 31 (4-9))

    Enfermedades Infecciosas y Microbiologia Clinica

  4. First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 57, Núm. 1, pp. 589-591